» Articles » PMID: 32391796

Human Exposure to Synthetic Endocrine Disrupting Chemicals (S-EDCs) is Generally Negligible As Compared to Natural Compounds with Higher or Comparable Endocrine Activity. How to Evaluate the Risk of the S-EDCs?

Abstract

Theoretically, both synthetic endocrine disrupting chemicals (S-EDCs) and natural (exogenous and endogenous) endocrine disrupting chemicals (N-EDCs) can interact with endocrine receptors and disturb hormonal balance. However, compared to endogenous hormones, S-EDCs are only weak partial agonists with receptor affinities several orders of magnitude lower. Thus, to elicit observable effects, S-EDCs require considerably higher concentrations to attain sufficient receptor occupancy or to displace natural hormones and other endogenous ligands. Significant exposures to exogenous N-EDCs may result from ingestion of foods such as soy-based diets, green tea and sweet mustard. While their potencies are lower as compared to natural endogenous hormones, they usually are considerably more potent. Effects of exogenous N-EDCs on the endocrine system were observed at high dietary intakes. A causal relation between their mechanism of action and these effects is established and biologically plausible. In contrast, the assumption that the much lower human exposures to S-EDCs may induce observable endocrine effects is not plausible. Hence, it is not surprising that epidemiological studies searching for an association between S-EDC exposure and health effects have failed. Regarding testing for potential endocrine effects, a scientifically justified screen should use in vitro tests to compare potencies of S-EDCs with those of reference N-EDCs. When the potency of the S-EDC is similar or smaller than that of the N-EDC, further testing in laboratory animals and regulatory consequences are not warranted.

Citing Articles

Toxicological Effects of Naturally Occurring Endocrine Disruptors on Various Human Health Targets: A Rapid Review.

Virtuoso S, Raggi C, Maugliani A, Baldi F, Gentili D, Narciso L Toxics. 2024; 12(4).

PMID: 38668479 PMC: 11054122. DOI: 10.3390/toxics12040256.


Advancing Endocrine Disruptors via In Vitro Evaluation: Recognizing the Significance of the Organization for Economic Co-Operation and Development and United States Environmental Protection Agency Guidelines, Embracing New Assessment Methods, and....

Fouyet S, Ferger M, Leproux P, Rat P, Dutot M Toxics. 2024; 12(3).

PMID: 38535916 PMC: 10974109. DOI: 10.3390/toxics12030183.